These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


258 related items for PubMed ID: 20453801

  • 21. [Triamcinolone in the treatment of the diabetic macular edema--one-year results].
    Dusová J, Studnicka J, Rencová E, Korda V, Hejcmanová D.
    Cesk Slov Oftalmol; 2008 Jul; 64(4):149-52. PubMed ID: 18780654
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. Multifocal electroretinography amplitudes increase after photocoagulation in areas with increased retinal thickness and hard exudates.
    Lövestam-Adrian M, Holm K.
    Acta Ophthalmol; 2010 Mar; 88(2):188-92. PubMed ID: 19220206
    [Abstract] [Full Text] [Related]

  • 26. The status of diabetic retinopathy and diabetic macular edema in patients with type 2 diabetes: a survey from Beixinjing District of Shanghai city in China.
    Wang N, Xu X, Zou H, Zhu J, Wang W, Ho PC.
    Ophthalmologica; 2008 Mar; 222(1):32-6. PubMed ID: 18097178
    [Abstract] [Full Text] [Related]

  • 27. Pars plana vitrectomy with removal of the internal limiting membrane in the treatment of persistent diabetic macular edema.
    Recchia FM, Ruby AJ, Carvalho Recchia CA.
    Am J Ophthalmol; 2005 Mar; 139(3):447-54. PubMed ID: 15767052
    [Abstract] [Full Text] [Related]

  • 28. Changes in choroidal thickness after panretinal photocoagulation in patients with type 2 diabetes.
    Zhu Y, Zhang T, Wang K, Xu G, Huang X.
    Retina; 2015 Apr; 35(4):695-703. PubMed ID: 25462436
    [Abstract] [Full Text] [Related]

  • 29. Prospective randomised controlled trial comparing sub-threshold micropulse diode laser photocoagulation and conventional green laser for clinically significant diabetic macular oedema.
    Figueira J, Khan J, Nunes S, Sivaprasad S, Rosa A, de Abreu JF, Cunha-Vaz JG, Chong NV.
    Br J Ophthalmol; 2009 Oct; 93(10):1341-4. PubMed ID: 19054831
    [Abstract] [Full Text] [Related]

  • 30. Effective treatment of diffuse diabetic macular edema by temporal grid pattern photocoagulation.
    Shimura M, Yasuda K, Nakazawa T, Ota S, Tamai M.
    Ophthalmic Surg Lasers Imaging; 2004 Oct; 35(4):270-80. PubMed ID: 15305550
    [Abstract] [Full Text] [Related]

  • 31. Comparison of the magnitude and time course of macular thinning induced by different interventions for diabetic macular edema: implications for sequence of application.
    Browning DJ, Fraser CM, Powers ME.
    Ophthalmology; 2006 Oct; 113(10):1713-9. PubMed ID: 16889833
    [Abstract] [Full Text] [Related]

  • 32. The longitudinal changes of retinal nerve fiber layer thickness after panretinal photocoagulation in diabetic retinopathy patients.
    Lee SB, Kwag JY, Lee HJ, Jo YJ, Kim JY.
    Retina; 2013 Jan; 33(1):188-93. PubMed ID: 22990321
    [Abstract] [Full Text] [Related]

  • 33. Functional and morphological changes of macula after subthreshold micropulse diode laser photocoagulation for diabetic macular oedema.
    Nakamura Y, Mitamura Y, Ogata K, Arai M, Takatsuna Y, Yamamoto S.
    Eye (Lond); 2010 May; 24(5):784-8. PubMed ID: 19680274
    [Abstract] [Full Text] [Related]

  • 34. Intravitreal triamcinolone acetonide for diffuse diabetic macular edema: phase 2 trial comparing 4 mg vs 2 mg.
    Audren F, Lecleire-Collet A, Erginay A, Haouchine B, Benosman R, Bergmann JF, Gaudric A, Massin P.
    Am J Ophthalmol; 2006 Nov; 142(5):794-99. PubMed ID: 16978576
    [Abstract] [Full Text] [Related]

  • 35. Intravitreal triamcinolone acetonide as an adjuvant therapy to panretinal photocoagulation for proliferative retinopathy with high risk characteristics in type 1 diabetes: case report with 22 weeks follow-up.
    Kytö JP, Angerman S, Lumiste E, Paloheimo M, Summanen PA.
    Acta Ophthalmol Scand; 2005 Oct; 83(5):605-8. PubMed ID: 16188001
    [Abstract] [Full Text] [Related]

  • 36. Short-duration focal pattern grid macular photocoagulation for diabetic macular edema: four-month outcomes.
    Jain A, Collen J, Kaines A, Hubschman JP, Schwartz S.
    Retina; 2010 Oct; 30(10):1622-6. PubMed ID: 21060272
    [Abstract] [Full Text] [Related]

  • 37. Retina rejuvenation therapy for diabetic macular edema: a pilot study.
    Pelosini L, Hamilton R, Mohamed M, Hamilton AM, Marshall J.
    Retina; 2013 Mar; 33(3):548-58. PubMed ID: 23023529
    [Abstract] [Full Text] [Related]

  • 38. Intravitreal triamcinolone for diabetic macular edema that persists after laser treatment: three-month efficacy and safety results of a prospective, randomized, double-masked, placebo-controlled clinical trial.
    Sutter FK, Simpson JM, Gillies MC.
    Ophthalmology; 2004 Nov; 111(11):2044-9. PubMed ID: 15522370
    [Abstract] [Full Text] [Related]

  • 39. Diabetic macular edema: correlation between microperimetry and optical coherence tomography findings.
    Vujosevic S, Midena E, Pilotto E, Radin PP, Chiesa L, Cavarzeran F.
    Invest Ophthalmol Vis Sci; 2006 Jul; 47(7):3044-51. PubMed ID: 16799051
    [Abstract] [Full Text] [Related]

  • 40. Changes in the Macular Ganglion Cell Complex Thickness and Central Macular Thickness after Argon Laser Panretinal Photocoagulation.
    Demirok G, Kocamaz MF, Topalak Y, Altay Y, Tabakci B, Şengün A.
    Semin Ophthalmol; 2017 Jul; 32(6):759-763. PubMed ID: 27715375
    [Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 13.